Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders

Published:2024-12 Issue: Volume:931 Page:148865
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Zanganeh Saeed^ORCID,Zahedi Amir Mohammad,Sattarzadeh Bardsiri Mahla,Bazi Ali,Bastanifard Mahdieh,Shool Sanaz,Kouhbananinejad Seyedeh Mehrnaz,Farsinejad Alireza,Afgar Ali,Shahabi Arman,Mirzaei-Parsa Mohamad Javad

Publisher

Elsevier BV

Reference124 articles.

1. Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products;Aiuti;EMBO Mol. Med.,2017

2. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms;Akinc;Mol. Ther.,2010

3. CRISPR/Cas13 as a tool for RNA interference;Ali;Trends Plant Sci.,2018

4. Gene therapy of hematological disorders: current challenges;Al-Saif;Gene Ther.,2019

5. The ethics of gene therapy for hemophilia: a narrative review;Baas;J. Thromb. Haemost.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP